Ann: IMUGENE RAISES $8.7 MILLION, page-2

@amcfutures , 80 & still going strong
One of my parents is mid 70s & dying from an incurable disease

Thank you for your objective & very cautious opinions, much appreciated.

@QiQi, seems like you have lots of knowledge in this. Love your positivity.

I'm just a passive investor, who have fortunately some funds (gained from lucky investment dealing throughout the years, I'm no business expert) which I can park it for a long time, and IMU seems like a good candidate for it, even though it's not a bluechip stock & quite risky.

Well, those who are bullish on IMU seems right so far! That's if you buy the story, & yes I do!

Fully underwritten, tick.

The purpose of the Equity Raising is to raise new funds for the following purposes:
1) Completion of a HER-Vax Phase 1b/2 clinical trial $9m
2) Completion of at least 2 investigator sponsored studies $1m
3) Identifying & developing mimotop candidates $1.1m
4) Securing mimotope intellectual property $0.25m
5) Offer costs $0.6m
6) Working capital $4.3m

Opening cash + R&D rebate -7.5m
Total funds raised $8.73m